Trial intelligence / Profile preview

Adjuvanted A/H1N1 Pandemic Vaccine in Adults and Elderly

NCT00952276Phase 2Completed

Sponsor
Sanofi
Start
Oct 2009
Primary completion
Dec 2010
Modality
Live Attenuated Vaccines, Whole Inactivated Vaccines
Countries
1
01

Overview

A Phase 2 trial of Influenza A (H1N1) vaccine in influenza A H1N1 infection (H1N1), sponsored by Sanofi. Started Oct 2009; status: completed.

02

Drugs

Influenza A (H1N1) vaccine
03

Conditions

influenza A H1N1 infection (H1N1)

Beyond the preview

Go deeper on NCT00952276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00952276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call